Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

DHA‑Licensed Genetic Testing · ISO 9001:2015 Cert: INT/EGQ/2509DA/3139

XRCC2 Gene Fanconi Anemia (XRCC2-Related) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين XRCC2 لفقر الدم فانكوني (مرتبط بـ XRCC2) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

الفحص الجيني المعتمد بموجب القانون الإماراتي يضمن الدقة والسرية التامة مع استشارة مجانية بعد الفحص. UAE’s only ISO 9001:2015‑accredited NGS test for XRCC2‑related Fanconi anemia – delivering 99.9% diagnostic sensitivity with full compliance to Federal Decree‑Law No. 41 of 2024, CDS Law 2026 (minors), and UAE PDPL.

  • Accuracy Guarantee: 99.9% Analytical Sensitivity via ISO‑accredited NGS processing.
  • Premium Home Collection: Hospital‑grade, cold‑chain phlebotomy (8 AM – 11 PM) with VIP mobile service.
  • Clinical Guidance: Complimentary post‑test tele‑consultation with a DHA‑licensed hematologist or genetic counselor.
  • Insurance & Verification: Direct billing verification via WhatsApp at +971 54 548 8731.

Test Overview & Competitive Edge

This test screens the XRCC2 gene for pathogenic variants linked to Fanconi anemia, a rare hereditary bone marrow failure syndrome. In just 3–4 weeks, we provide a clinically actionable report that empowers Hematologists, Oncologists, and Genetic Counselors to confirm diagnosis, guide treatment, and assess family risk. يكشف الفحص طفرات جين XRCC2 المسؤولة عن فقر الدم فانكوني، ويُستخدم لتأكيد التشخيص وتوجيه العلاج وحساب المخاطر العائلية.

Feature Our Test (PrimeGen) Closest Alternative
Methodology Next‑Generation Sequencing (NGS) – full gene coverage Targeted mutation panel (may miss novel variants)
Diagnostic Sensitivity >99.9% ~85–92%
Turnaround Time 3–4 Weeks 5–7 Weeks
Legal Compliance FD Law 41/2024, CDS 2026, UAE PDPL Limited or non‑local
Home Collection 8 AM – 11 PM, cold‑chain, DHA‑licensed May require in‑clinic visit

Physician Insight & Clinical Safety Protocol

A Note from Dr. Prabhakar Reddy (DHA License 61713011, Hematology):

"The XRCC2 assay offers profound insights into inherited bone marrow failure, yet no single test replaces a thorough clinical evaluation. I urge every patient to interpret these findings alongside a complete blood count, physical exam, and family pedigree. Always maintain your prescribed regimen and share all results with your treating physician."

🚨 Medication Warning

Do not discontinue any prescribed medication (e.g., androgens, G‑CSF, or transfusions) without direct instruction from your consultant. Stopping treatment abruptly can precipitate severe marrow failure.

Safety Exclusion Criteria & Emergency Red Flags

  • Exclusion: Testing cannot proceed without a completed clinical history form and, for minors, legally mandated parental consent (CDS Law 2026).
  • Exclusion: Specimens that do not meet cold‑chain requirements or are collected on expired FTA cards will be rejected.
  • Emergency: If you develop sudden, unexplained bruising, severe fatigue, shortness of breath, or recurrent infections, seek immediate medical attention at the nearest emergency department—these may signal acute bone marrow failure.

Patient FAQ & Clinical Guidance

1. What is the XRCC2 Fanconi anemia test and who should consider it?

The XRCC2 NGS test detects pathogenic variants in the XRCC2 gene that cause Fanconi anemia, a hereditary bone marrow failure syndrome. It is recommended for individuals with unexplained cytopenias, a family history of Fanconi anemia, or prior inconclusive genetic screenings. Hematologists, oncologists, and genetic counselors use this test to confirm diagnosis, assess cancer predisposition, and guide family planning. يُستخدم تحليل جين XRCC2 لتأكيد تشخيص فقر الدم فانكوني وتقييم مخاطر السرطان لدى الأفراد والعائلات المشتبهة.

2. How accurate and fast is the test, and what does the price include?

The test delivers >99.9% analytical sensitivity and specificity with results returned in 3 to 4 weeks. The 2800 AED fee covers the full sequencing and bioinformatic interpretation, a pre‑test genetic counselling session, home or clinic sample collection, and a post‑ tele‑consultation with a DHA‑licensed specialist to explain your report. تصل حساسية الفحص إلى أكثر من 99.9% وتظهر النتائج خلال 3 إلى 4 أسابيع، بما في ذلك الاستشارة الوراثية وخدمة السحب المنزلي.

3. What do I need to prepare before giving a sample?

You must provide a detailed personal and family clinical history and attend a genetic counseling session to draw a pedigree chart. No fasting is required. The sample can be whole blood, extracted DNA, or a single drop of blood on an FTA card. Our phlebotomist will ensure proper collection and cold‑chain transport. Any medications or transfusions should be documented but not stopped without medical advice. يجب تقديم تاريخ سريري مفصل وحضور جلسة استشارة وراثية لرسم شجرة العائلة قبل الفحص. لا يشترط الصيام، ويمكن استخدام عينة دم أو بطاقة FTA.

Licensed by DHA/MOHAP Facility No. 9834453 | Certified ISO 9001:2015 (INT/EGQ/2509DA/3139) | All testing adheres to Federal Decree‑Law No. 41 of 2024, CDS Law 2026, and UAE PDPL.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians